CVKD
Price
$7.83
Change
-$0.22 (-2.73%)
Updated
Sep 6 closing price
61 days until earnings call
VINC
Price
$0.71
Change
-$0.04 (-5.33%)
Updated
Sep 6 closing price
62 days until earnings call
Ad is loading...

CVKD vs VINC

Header iconCVKD vs VINC Comparison
Open Charts CVKD vs VINCBanner chart's image
Cadrenal Therapeutics
Price$7.83
Change-$0.22 (-2.73%)
Volume$14.11K
CapitalizationN/A
Vincerx Pharma
Price$0.71
Change-$0.04 (-5.33%)
Volume$220.62K
CapitalizationN/A
View a ticker or compare two or three
CVKD vs VINC Comparison Chart
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CVKD vs. VINC commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Buy and VINC is a Hold.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (CVKD: $8.05 vs. VINC: $0.74)
Brand notoriety: CVKD and VINC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 51% vs. VINC: 133%
Market capitalization -- CVKD: $8.36M vs. VINC: $22.05M
CVKD [@Biotechnology] is valued at $8.36M. VINC’s [@Biotechnology] market capitalization is $22.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 1 FA rating(s) are green whileVINC’s FA Score has 1 green FA rating(s).

  • CVKD’s FA Score: 1 green, 4 red.
  • VINC’s FA Score: 1 green, 4 red.
According to our system of comparison, CVKD is a better buy in the long-term than VINC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 5 TA indicator(s) are bullish while VINC’s TA Score has 4 bullish TA indicator(s).

  • CVKD’s TA Score: 5 bullish, 5 bearish.
  • VINC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CVKD is a better buy in the short-term than VINC.

Price Growth

CVKD (@Biotechnology) experienced а +8.93% price change this week, while VINC (@Biotechnology) price change was -11.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

CVKD is expected to report earnings on Nov 07, 2024.

VINC is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VINC($22M) has a higher market cap than CVKD($8.36M). CVKD YTD gains are higher at: -27.468 vs. VINC (-37.280). CVKD has higher annual earnings (EBITDA): -6.23M vs. VINC (-28.94M). VINC has more cash in the bank: 16.3M vs. CVKD (5.04M). CVKD has less debt than VINC: CVKD (8.8K) vs VINC (1.93M). CVKD (0) and VINC (0) have equivalent revenues.
CVKDVINCCVKD / VINC
Capitalization8.36M22M38%
EBITDA-6.23M-28.94M22%
Gain YTD-27.468-37.28074%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.04M16.3M31%
Total Debt8.8K1.93M0%
TECHNICAL ANALYSIS
Technical Analysis
CVKDVINC
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKEY2.290.06
+2.92%
WISeKey International Holding Ltd
AKYA2.380.04
+1.71%
Akoya BioSciences
SGRY30.990.05
+0.16%
Surgery Partners
MTB168.80-0.16
-0.09%
M&T Bank Corp
BHLB26.62-0.12
-0.45%
Berkshire Hills Bancorp

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-0.74%
GDTC - CVKD
29%
Poorly correlated
N/A
REVB - CVKD
26%
Poorly correlated
-8.98%
VINC - CVKD
26%
Poorly correlated
-5.01%
TCRT - CVKD
24%
Poorly correlated
+0.80%
RNXT - CVKD
24%
Poorly correlated
-0.99%
More

VINC and

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with APVO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-5.01%
APVO - VINC
33%
Loosely correlated
-5.07%
INKT - VINC
33%
Poorly correlated
-1.15%
VBIVQ - VINC
32%
Poorly correlated
-11.25%
RNA - VINC
31%
Poorly correlated
-2.28%
VNDA - VINC
30%
Poorly correlated
+0.20%
More